Abstract |
|
Authors | Yun Wang, Jia-Huan Lu, Feng Wang, Ying-Nan Wang, Ming-Ming He, Qi-Nian Wu, Yun-Xin Lu, Hong-En Yu, Zhan-Hong Chen, Qi Zhao, Jia Liu, Yan-Xing Chen, De-Shen Wang, Hui Sheng, Ze-Xian Liu, Zhao-Lei Zeng, Rui-Hua Xu, Huai-Qiang Ju |
Journal | Cancer letters
(Cancer Lett)
Vol. 473
Pg. 74-89
(03 31 2020)
ISSN: 1872-7980 [Electronic] Ireland |
PMID | 31904482
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Fatty Acids
- NFATC Transcription Factors
- NFATC3 protein, human
- Reactive Oxygen Species
- Oxaliplatin
- NADP
- CPT1B protein, human
- Carnitine O-Palmitoyltransferase
- Perhexiline
|
Topics |
- Animals
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology, therapeutic use)
- Carcinogenesis
(drug effects, pathology)
- Carnitine O-Palmitoyltransferase
(antagonists & inhibitors, metabolism)
- Cell Line, Tumor
- Colorectal Neoplasms
(drug therapy, pathology)
- Drug Synergism
- Fatty Acids
(metabolism)
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Mice
- NADP
(metabolism)
- NFATC Transcription Factors
(metabolism)
- Oxaliplatin
(pharmacology, therapeutic use)
- Perhexiline
(pharmacology, therapeutic use)
- Reactive Oxygen Species
- Stomach Neoplasms
(drug therapy, pathology)
- Up-Regulation
(drug effects)
- Xenograft Model Antitumor Assays
|